corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library

Items published during the years 1970 to 1979

There are 379 items in the Healthy Skepticism Library that were published during the years 1970 to 1979.

Page 3 of 4 pages  < 1 2 3 4 > 

HSL8573
Whitney HA Jr.
Educating the public about drugs.
Drug Intell Clin Pharm 1975 Oct; 9:(10):571

HSL8846
Kleinfeld VA.
Overview of some recent developments in the drug field
Food Drug Cosmet Law J 1975 Aug; 30:458-468

HSL8844
Stetler CJ.
Are drug prices an profits without honor?
Medical Marketing and Media 1975 Jul; 10:11-12, 14, 16

HSL8849
Kushner D.
FTC's rules: get set for long controversy
American Druggist 1975 Jul; 172:18, 37-44, 47

HSL8847
Mant A.
Determinants of prescribing of psychoactive drugs by general practitioners.
Med J Aust 1975 Jun 14; 1:(24):743-9

HSL2062
Stimson GV.
The message of psychotropic drug ads.
J Commun 1975 Summer; 25:(3):153-60

HSL2843
Harelik JH, Johnston PM, Rivers NP, Ryan MR.
Pharmacist and physician evaluation of drug information sources.
Am J Hosp Pharm 1975 Jun; 32:(6):594-7

HSL2842
Bell W
The Compendium of Pharmaceuticals and Specialties
1975 May 30-31;

HSL2846
Mailloud J.
The drug companies role in the supply of information
1975 May 30-31;

HSL2855
Stimson G.
Women in a doctored world
New Society 1975 May 1; 32:265-267

HSL2852
Williamson PM.
How general practitioners assess risks in using new drugs.
J R Coll Gen Pract 1975 May; 25:(154):383-6

HSL8845
Ellenhorn MJ.
Future shock: drug therapy and the US pharmaceutical industry
Journal of Clinical Pharmacology 1975 May-Jun; 15:385-400
http://jcp.sagepub.com/cgi/reprint/15/5/385

HSL8851
Barrows J.
Prescription drug labeling for patients
Food Drug Cosmet Law J 1975 Feb; 30:98-104

HSL8855
Hemminki E.
Review of literature on the factors affecting drug prescribing.
Soc Sci Med 1975 Feb; 9:(2):111-6

HSL2849
Prather J, Fidell LS.
Sex differences in the content and style of medical advertisements.
Soc Sci Med 1975 Jan; 9:(1):23-6

HSL2850
Smith GH, Sorby DL, Sharp LJ.
Physician attitudes toward drug information resources.
Am J Hosp Pharm 1975 Jan; 32:(1):19-25

HSL8839
Higgins DG.
Aspects of medical communications in the United Kingdom.
Drug Inf J 1975 Jan-Apr; 9:(1):32-7

HSL2841
Prescription drug ads now to be prescreened
Canadian Family Physician 1975; 21:(8):23

HSL2844
Huse KD.
Medical advertising—the other side of the coin
Patient Management 1975; 4:(6):36-37

HSL2845
Kales A, Kales JD.
Shortcomings in the evaluation and promotion of hypnotic drugs
New England Journal of Medicine 1975; 293:826-827

HSL2847
Mant A, Darroch DB.
Media images and medical images
Social Science and Medicine 1975; 9:613-618

HSL2848
McCaffery M.
The muzzle muddle
Canadian Family Physician 1975; 21:(11):7

HSL2851
Telser L, Best W, Egan JW, Higinbotham HN.
The theory of supply with applications to the ethical pharmaceutical industry
Journal of Law and Economics 1975; 18:449-478

HSL2853
Responsible advertising
Medical Journal of Australia 1975; 62:90

HSL2854
Erill S, Souich PD, Garcia-Sevilla JA.
Chloramphenicol-containing drugs. A report from Spain
J Clin Pharmacol . 1975; 15:401-404
http://jcp.sagepub.com/cgi/reprint/15/5/401

HSL8576
Rucker TD.
Role of the pharmaceutical industry in a dynamic health care system
Drugs Health Care 1975; 2:(2):86-95

HSL8577
Lee AM.
Interdependence of prescription drugs and other health care costs
Drugs Healt -Care 1975; 2:(2):75-85

HSL8578
Hornbrook MC.
Commentary on the interdependence of prescription drugs and other health care costs: some implications for research
Drugs Health Care 1975; 2:(4):255-265

HSL8850
Pharmacy board not authorized to prohibit drug price advertising
Citation 1975; 30:(6):

HSL8856
Manufacturer liable for erroneous drug addiction claims
Citation 1975; 30:(7):107-108

HSL9052
Illich I.
Medical Nemesis
: Calder & Boyar 1975
http://www.amazon.com/Medical-Nemesis-Ivan-Illich/dp/0394712455

HSL9059
Klass A.
There's Gold in Them Thar Pills: An Enquiry into the Medical-Industrial Complex
: Penguin 1975
http://www.amazon.com/Theres-Gold-Them-Pills-Medical-Industrial/dp/0140523146/ref=sr_1_1/102-1249992-1219339?ie=UTF8&s=books&qid=1175165931&sr=1-1

HSL12234
Levine JM, Valle RS.
The convert as a credible communicator
Social Behavior and Personality 1975; 3:81-90

HSL2825
Woods D.
Prescription drugs and the patient's health.
Can Med Assoc J 1974 Dec 7; 111:(11):1269

HSL8858
Steiner KC, Garner DD.
Price as a component of prescription drug advertising
Medical Marketing and Media 1974 Dec; 9:15-20

HSL2840
Dryden A.
PMAC setting up board to pre-clear ads
Maclean Hunter 1974 Nov 18; 79:3

HSL2817
Mcree C, Corder BF, Haizlip T.
Psychiatrists' responses to sexual bias in pharmaceutical advertising.
Am J Psychiatry 1974 Nov; 131:(11):1273-5

HSL8569
Response of the American Pharmaceutical Association to the June 14, 1974, inquiry of the Federal Trade Commission.
J Am Pharm Assoc 1974 Oct; 14:(10):538-42,

HSL2819
Moser RH.
Editorial: The continuing search: FDA drug information survey.
JAMA 1974 Sep 2; 229:(10):1336-8

HSL2810
Erill S.
Clinical pharmacology in Spain.
Clin Pharmacol Ther 1974 Sep; 16:(3):597-604

HSL2839
Editorial
Advertising standards and the National Medical Media Council.
Med J Aust. 1974 Aug 10; 2:(6):189-90

HSL2838
Siegelman S.
How pharmacists rate detailmen
American Druggist 1974 Aug 1; 170:(3):19, 56-62

HSL2821
Schreier HA, Berger L.
Letter: On medical imperialism.
Lancet 1974 Jun 8; 1:(7867):1161

HSL8862
Walters PG.
FDA's program to improve consumers' and health professionals' ability to select medically effective drugs
Hosp Formul Manage 1974 Jun; 9:17-20, 50

HSL2826
Gould D.
Can we handle modern drugs?
New Scientist 1974 May 23; 62:(899):460-1

HSL2827
Greenberg D.
Cleaning up the drug trade
New Scientist 1974 May 23; 62:491

HSL8869
Inquisitive Federal Trade Commission (FTC) starts poking into pharmacy field
American Druggist 1974 May 1; 169:74-75

HSL8854
Schamberg IL.
The quality and cost of prescription drugs.
J Am Pharm Assoc 1974 May; 14:(5):241-3

HSL8861
Pendergast WR.
FDA regulations-a ten-year assessment
Medical Marketing and Media 1974 May; 9:20, 22, 26-27

HSL2813
Hemminki E.
The effect of a doctor's personal characteristics and working circumstances on the prescribing of psychotropic drugs.
Med Care 1974 Apr; 12:(4):351-7

HSL8870
Decristoforo R, Fortner CL.
Review of potential drug interactions between OTC (over-the-counter) and prescription drugs
Hosp Formul Manage 1974 Apr; 10:20-31, 41

HSL8866
Davis S.
Update on computerized media evaluation
Medical Marketing and Media 1974 Mar; 9:13-15

HSL8874
Display the prescription price poster, but not too conspicuously
Am Drug Merch 1974 Feb 1; 169:32-36, 46

HSL8859
Miller R.
Prescribing habits of physicians. Parts 7-8. Sources of information on drugs and their influence on prescribing and a theoretical model for the adoption of drug innovations
Drug Intell Clin Pharm 1974 Feb; 8:81-91

HSL8863
Hoare RG.
Pharmaceutical company
Postgrad Med J 1974 Feb; 50:85-87

HSL2806
Denies ads mislead, manipulate
Drug Merchandising 1974; 55:(4):51

HSL2807
Findings and conclusions of the NCCC [National Council of Churches of Christ] project on drug advertising
Journal of Drug Issues 1974; 4:310-312

HSL2808
Bowes R.
The industry as pusher
Journal of Drug Issues 1974; 4:238-242

HSL2809
Cooperstock R.
Some factors involved in the increased prescribing of psychotropic drugs
Alcoholism and Drug Addiction Research Foundation of Ontario 1974;

HSL2811
Greenfield P, Wolff F.
The pressures of drug advertising on physicians and patients
Journal of Drug Issues 1974; 4:254-259

HSL2812
Hay DR.
Postal pollution
New Zealand Medical Journal 1974; 80:464

HSL2814
Hess SW.
Communicating with physicians
Journal of Advertising Research 1974; 14:(1):13-18

HSL2815
Kallir J.
An advertiser’s view of drug advertising
Journal of Drug Issues 1974; 4:283-286

HSL2816
Knight JL, Baumgartner RP.
Quality control information—its availability from pharmaceutical manufacturers
Hospital Formulary Management 1974; 9:(9):35, 37, 40-42, 50

HSL2818
Miller RR.
Prescribing habits of physicians: a review of studies on prescribing of drugs. Parts VII-Viii
Drug Intelligence and Clinical Pharmacy 1974; 8:81-91

HSL2820
Nelson G.
New laws are needed to regulate the drug industry
Journal of Drug Issues 1974; 4:243-248

HSL2822
Seidenberg R.
Images of health, illness and women in drug advertising
Journal of Drug Issues 1974; 4:264-267

HSL2823
Turner J.
Weaknesses in the system of promoting and marketing drugs
Journal of Drug Issues 1974; 4:260-263

HSL2824
Wolfe SM.
Scientific evaluations dispute advertising claims
Journal of Drug Issues 1974; 4:249-253

HSL2828
Barclay WR.
The American Medical Association's policy on drug advertising
Journal of Drug Issues 1974; 4:287-290

HSL2829
Berger AA.
Drug advertising and the "pain, pill, pleasure" model
Journal of Drug Issues 1974; 4:208-212

HSL2830
Braren W.
Deception in advertising and the failure of self-regulation
Journal of Drug Issues 1974; 4:213-216

HSL2831
Donegan TJ.
The role of the Federal Trade Commission in regulating over-the-counter drug advertising
Journal of Drug Issues 1974; 4:232-237

HSL2832
Johnson N.
Junkie television
Journal of Drug Issues 1974; 4:227-231

HSL2833
Kanter DL.
Research on the effects of over-the-counter drug advertising
Journal of Drug Issues 1974; 4:223-226

HSL2834
Panel , Donegan , Warnke , Bowes , Turner , Stetler , Simmons .
Special discussion of two major questions
Journal of Drug Issues 1974; 4:297-309

HSL2835
Penna RD.
American Pharmaceutical Association
Journal of Drug Issues 1974; 4:268-273

HSL2836
Simmons H.
The role of the Food and Drug Administration in regulating drug advertising
Journal of Drug Issues 1974; 4:291-296

HSL2837
Warnke P, O'Keefe D, Kiev A.
The Proprietary Association replies to the critics
Journal of Drug Issues 1974; 4:217-222

HSL8864
Dyer AE.
PARCOST: the Ontario experience in selecting quality drugs
Drugs Health Care 1974; 1:(1):16-26

HSL8865
Bowes R.
Industry as pusher
Journal of Drug Issues 1974; 4:(3):238-242

HSL8868
Stetler CJ, Coe F.
Pharmaceutical Manufacturers Association responds to the critics
Journal of Drug Issues 1974; 4:(3):274-282

HSL8878
Turnbull JC.
Can Pharm Ass rejects prescription advertising
Canadian Pharmaceutical Journal 1973 Dec; 106:368-372

HSL8872
Wertheimer AI, Knoben JE.
The mail-order prescription drug industry.
Health Serv Rep 1973 Nov; 88:(9):852-6
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=4586284

HSL8879
Segal HJ.
Ontario's PARCOST (prescriptions at reasonable cost) program
Canadian Pharmaceutical Journal 1973 Nov; 106:346-351

HSL8876
Huskisson EC.
Trade names or proper names? A problem for the prescriber
British Medical Journal 1973 Oct 27; 4:225-228
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=4758398

HSL2804
Dunne M, Newman M, Herxheimer A, Ridley H.
Indications and warnings about chloramphenicol.
Lancet 1973 Oct 6; 2:(7832):781-3

HSL2342
Waxburg JD.
What motivates a physician to try a new product?
Med Mark Media 1973 Jul 8; 13-15

HSL8857
Brogle RC.
Effect of the OTC review on the future of proprietary drug research
Drug Information Journal 1973 Jul-Dec; 7:71-74

HSL2803
Williams JD, Geddes AM.
Advertising of antibiotics.
Br Med J 1973 Jun 9; 2:(5866):613

HSL1880
Goulston K.
Problems of postgraduate medical education.
Aust N Z J Med 1973 Jun; 3:(3):230-8

HSL2798
Parish PA.
What influences have led to increased prescribing of psychotropic drugs?
J R Coll Gen Pract 1973 Jun; 23:Suppl:

HSL2799
Simpson FO.
Omissions in advertising.
N Z Med J 1973 Jun; 77:(493):412

HSL2802
Worthen DB.
Prescribing influences: an overview.
Br J Med Educ 1973 Jun; 7:(2):109-17

HSL8873
Thompson AWS.
Prescribing of hypnotics and tranquilizers in New Zealand
Pharm J N Z 1973 Apr; 35:15-18

HSL8848
Sonnedecker G.
American pharmacy--a retrospective future.
J Am Pharm Assoc 1973 Mar; 13:(3):128-30

HSL2794
Hemminki E.
The quality of drug advertisements in two Finnish medical journals. A comparison between psychotropic and other drug advertisements
Soc Sci Med. 1973 Jan 01; 7:(1):51-9

HSL2795
Kunnes R.
Drugs and public policy: Poly-drug abuse: drug companies and doctors
American Journal of Orthopsychiatry 1973; 43:530-2

HSL2796
Miller RR.
Prescribing habits of physicians: a review of studies on prescribing of drugs. Parts I-III
Drug Intelligence and Clinical Pharmacy 1973; 7:492-500

HSL2797
Miller RR.
Prescribing habits of physicians: a review of studies on prescribing of drugs. Parts IV-VI
Drug Intelligence and Clinical Pharmacy 1973; 7:557-564

Page 3 of 4 pages  < 1 2 3 4 > 

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.







You are going to have many difficulties. The smokers will not like your message. The tobacco interests will be vigorously opposed. The media and the government will be loath to support these findings. But you have one factor in your favour. What you have going for you is that you are right.
- Evarts Graham
See:
When truth is unwelcome: the first reports on smoking and lung cancer.